# Incidence of de novo HPV infections in a previous HPV-negative group, related to use of different contraceptive methods: a retrospective cohort study

**Authors:** Lina Jans, Jan Brynhildsen, Joar Hofgaard, Safia Ansari, Lovisa Eklöf, Lovisa Bergengren

PMC · DOI: 10.1186/s13027-025-00688-6 · Infectious Agents and Cancer · 2025-08-05

## TL;DR

This study examines how different contraceptive methods, including IUDs, affect the risk of new HPV infections in women previously HPV-negative.

## Contribution

The study provides new insights into the relationship between contraceptive use and HPV incidence, focusing on different IUD types.

## Key findings

- Hormonal contraception users had a higher incidence of HPV (5.6%) compared to non-users (4.2%).
- No significant difference in HPV incidence was found between users of hormonal IUDs and copper IUDs.
- Consistent contraceptive use showed no significant change in HPV incidence over time.

## Abstract

Users of intrauterine devices (IUDs) have been found to have a lower incidence of cervical cancer in meta-analyses, but these studies have not been able to examine the influence of IUD type. The aim of this study is to investigate the incidence of de novo high-risk human papillomavirus (HPV) infections in relation to the reported use of contraceptive methods, with special regard to different types of IUDs.

A sample of participants in the national screening program for cervical cancer (n = 11,702) with a negative HPV test in 2017–2018 were included. Their subsequent HPV test results in 2020–2023 were analyzed in relation to their reported contraceptive method.

Participants who reported use of hormonal contraception had higher incidence of a positive HPV screening test (5.6%) compared with women with no reported contraception (4.2%) (OR 1.29; 95% CI 1.01–1.64). There was no significant difference in HPV incidence among women who reported use of hormonal IUD (HIUD) or copper-containing IUD (CU-IUD). Women who reported use of the same contraceptive method in both screening rounds showed no significant differences in HPV incidence, regardless of the contraceptive method they had used.

The incidence of de novo HPV infections is not significantly different in users of different types of IUD.

## Linked entities

- **Diseases:** cervical cancer (MONDO:0002974)

## Full-text entities

- **Diseases:** HPV infections (MESH:D030361), cervical cancer (MESH:D002583)
- **Chemicals:** CU (MESH:D003300)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human papillomavirus (species) [taxon 10566]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12326846/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12326846/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12326846/full.md

---
Source: https://tomesphere.com/paper/PMC12326846